We've decided recently that our general investment methodology, called relative trend analysis™ (RTA) , could also form the basis for one or more web sites that focus on specific niche markets that might draw an investor following. This is our first experiment along those lines.
There are approximately 200 publicly traded cannabis-related stocks listed on North American stock exchanges. You wouldn't want to touch 100 of those under any circumstances.
We've chosen the "elite" from the original list, although we would still warn you that most of these are still small, poorly capitalized companies with no profits. Almost all fall into the penny stock category.
That will change, and we think that now is the time to start tracking the performance of some of these stocks on a weekly basis. A majority of US states now approve sales of marijuana for at least medicinal purposes. And legalized recreational use is on the rise too.
Why not use some discretionary capital to invest in some of the publicly traded pioneers, who are preparing themselves for full legalization across the board? These won't be just growers. There are the distributors. The associated health care companies. The financiers. The accessories suppliers ("head shops"). Even specialized real estate companies.
This is both a "gold rush" and a "wild west" opportunity that is not for the faint-of-heart investor. Small companies. No profits. Poor financing. But it won't stay that way for much longer.
Learn our methodology and start nibbling at a few promising opportunities.